Cellular factors influence the binding of HIV type 1 to cells

AIDS Research and Human Retroviruses

Volumn 18, Issue 4, 2002, Pages 259-267

  Olinger, Gene G ^a   Saifuddin, Mohammed ^a   Hart, Melanie L ^a   Spear, Gregory T ^a  

^a RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41;

ARTICLE; CELL LINE; CELL TYPE; CONTROLLED STUDY; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE; TARGET CELL; VIRION; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS STRAIN;

CELL LINE; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MEMBRANE FUSION;

EID: 0036206479     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202753472838     Document Type: Article

References (49)

1. The role of herpes simplex virus glycoproteins in the virus replication cycle
2. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate
3. Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells
4. Neutralized vesicular stomatitis virus binds to host cells by a different "receptor
5. Adsorption of Rous sarcoma virus to genetically susceptible and resistant chicken cells studied by laser flow cytometry
6. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction
7. HIV entry and tropism. When one receptor is not enough
8. CD4-negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells
9. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy
10. Follicular dendritic cells and human immunodeficiency virus infectivity
11. Follicular dendritic cells (FDC) in retroviral infection: Host/pathogen perspectives
12. B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1
13. Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes
14. Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC)
15. Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells
16. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization
17. Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells
18. The acquisition of host-encoded proteins by nascent HIV-1
19. Characterization of recombinant human interleukin-2 with micromethods
20. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system
21. Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis
22. An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1
23. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines
24. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV
25. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific
26. Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: Correlation with stage of disease and presence of opportunistic infection
27. Transfer of host T-cell membrane HLA-DR and CD25 to target cells by human retroviruses
28. Uptake of duck hepatitis B virus into hepatocytes occurs by endocytosis but does not require passage of the virus through an acidic intracellular compartment
29. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated
30. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans
31. Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells
32. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity
33. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules
34. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity
35. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1
36. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization
37. Role of host cell proteins in HIV-1 infection
38. Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1
39. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
40. Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4
41. Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: Investigation of the mechanism of inhibition
42. Separable mechanisms of attachment and cell uptake during retrovirus infection
43. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
44. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells
45. + T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1
46. Retroviral infection is limited by brownian motion
47. Quantitation of human immunodeficiency virus type 1 infection kinetics
48. Enhancement of human immunodeficiency virus type 1 infection by cationic liposomes: The role of CD4, serum and liposome-cell interactions
49. The physico-chemical factors that govern retrovirus-mediated gene transfer